Otsuka Holdings Co., Ltd. (OTSKY)
USD 27.55
(-0.4%)
USD 27.55
(-0.4%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 249.58 Billion JPY | 11.67% |
| 2022 | 223.5 Billion JPY | 23.93% |
| 2021 | 180.35 Billion JPY | 3.75% |
| 2020 | 173.82 Billion JPY | 8.65% |
| 2019 | 159.99 Billion JPY | 1.82% |
| 2018 | 157.12 Billion JPY | 8.71% |
| 2017 | 144.53 Billion JPY | 8.06% |
| 2016 | 133.75 Billion JPY | -7.68% |
| 2015 | 144.88 Billion JPY | 1.09% |
| 2014 | 143.33 Billion JPY | 8.3% |
| 2013 | 132.35 Billion JPY | 10.88% |
| 2012 | 119.36 Billion JPY | 3.92% |
| 2011 | 114.86 Billion JPY | -0.48% |
| 2010 | 115.41 Billion JPY | 10.97% |
| 2009 | 104 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 273.82 Billion JPY | 9.71% |
| 2024 Q2 | 296.77 Billion JPY | 8.38% |
| 2023 Q3 | 251.14 Billion JPY | 0.09% |
| 2023 FY | 249.58 Billion JPY | 11.67% |
| 2023 Q4 | 249.58 Billion JPY | -0.62% |
| 2023 Q1 | 238.9 Billion JPY | 6.89% |
| 2023 Q2 | 250.91 Billion JPY | 5.03% |
| 2022 Q3 | 229.26 Billion JPY | 5.31% |
| 2022 Q4 | 223.5 Billion JPY | -2.51% |
| 2022 Q2 | 217.69 Billion JPY | 10.88% |
| 2022 FY | 223.5 Billion JPY | 23.93% |
| 2022 Q1 | 196.34 Billion JPY | 8.87% |
| 2021 Q2 | 182.05 Billion JPY | -0.41% |
| 2021 Q3 | 178.89 Billion JPY | -1.74% |
| 2021 Q4 | 180.35 Billion JPY | 0.82% |
| 2021 FY | 180.35 Billion JPY | 3.75% |
| 2021 Q1 | 182.8 Billion JPY | 5.17% |
| 2020 Q2 | 179.61 Billion JPY | 7.92% |
| 2020 FY | 173.82 Billion JPY | 8.65% |
| 2020 Q3 | 172.06 Billion JPY | -4.2% |
| 2020 Q4 | 173.82 Billion JPY | 1.02% |
| 2020 Q1 | 166.43 Billion JPY | 4.03% |
| 2019 FY | 159.99 Billion JPY | 1.82% |
| 2019 Q1 | 165.36 Billion JPY | 5.24% |
| 2019 Q4 | 159.99 Billion JPY | -4.33% |
| 2019 Q3 | 167.23 Billion JPY | -0.97% |
| 2019 Q2 | 168.87 Billion JPY | 2.12% |
| 2018 FY | 157.12 Billion JPY | 8.71% |
| 2018 Q4 | 157.12 Billion JPY | -4.8% |
| 2018 Q3 | 165.04 Billion JPY | 2.74% |
| 2018 Q2 | 160.64 Billion JPY | 5.36% |
| 2018 Q1 | 152.46 Billion JPY | 5.49% |
| 2017 Q1 | 143.1 Billion JPY | 6.99% |
| 2017 FY | 144.53 Billion JPY | 8.06% |
| 2017 Q4 | 144.53 Billion JPY | -3.77% |
| 2017 Q3 | 150.2 Billion JPY | 0.83% |
| 2017 Q2 | 148.96 Billion JPY | 4.1% |
| 2016 FY | 133.75 Billion JPY | -7.68% |
| 2016 Q4 | 133.75 Billion JPY | -6.59% |
| 2016 Q3 | 143.19 Billion JPY | -1.84% |
| 2016 Q2 | 145.87 Billion JPY | -2.17% |
| 2016 Q1 | 149.11 Billion JPY | 2.91% |
| 2015 Q2 | 160.88 Billion JPY | 0.79% |
| 2015 Q3 | 158.56 Billion JPY | -1.45% |
| 2015 Q4 | 144.88 Billion JPY | -8.62% |
| 2015 Q1 | 159.62 Billion JPY | 0.0% |
| 2015 FY | 144.88 Billion JPY | 1.09% |
| 2014 Q3 | 158.42 Billion JPY | 0.8% |
| 2014 FY | 143.33 Billion JPY | 8.3% |
| 2014 Q2 | 157.16 Billion JPY | 3.49% |
| 2014 Q1 | 151.86 Billion JPY | 4.2% |
| 2013 Q3 | 142.66 Billion JPY | -0.65% |
| 2013 Q4 | 145.74 Billion JPY | 2.16% |
| 2013 Q1 | 132.35 Billion JPY | 1.01% |
| 2013 FY | 132.35 Billion JPY | 10.88% |
| 2013 Q2 | 143.6 Billion JPY | 8.5% |
| 2012 FY | 119.36 Billion JPY | 3.92% |
| 2012 Q4 | 131.02 Billion JPY | 0.59% |
| 2012 Q3 | 130.25 Billion JPY | 1.41% |
| 2012 Q2 | 128.44 Billion JPY | 7.61% |
| 2012 Q1 | 119.36 Billion JPY | -4.45% |
| 2011 Q2 | 118.03 Billion JPY | 2.76% |
| 2011 Q1 | 114.86 Billion JPY | -0.91% |
| 2011 Q3 | 127.92 Billion JPY | 8.38% |
| 2011 Q4 | 124.92 Billion JPY | -2.35% |
| 2011 FY | 114.86 Billion JPY | -0.48% |
| 2010 Q4 | 115.91 Billion JPY | -3.9% |
| 2010 Q3 | 120.61 Billion JPY | -4.12% |
| 2010 Q1 | 115.41 Billion JPY | 5.99% |
| 2010 FY | 115.41 Billion JPY | 10.97% |
| 2010 Q2 | 125.79 Billion JPY | 8.99% |
| 2009 Q3 | 110.13 Billion JPY | -3.61% |
| 2009 FY | 104 Billion JPY | 0.0% |
| 2009 Q4 | 108.89 Billion JPY | -1.12% |
| 2009 Q2 | 114.25 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -4507.926% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -9275.695% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -56311.225% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -1755781.525% |
| Novartis AG | 5.91 Billion USD | -4120.886% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -55205.146% |